Skip to content
OpenCapital
Get started

Eledon Pharmaceuticals, Inc. ELDN Q1 2026 earnings

Reported May 13, 2026 · Before market open

EPS-$0.33Miss by $0.11
EPS estimate-$0.22

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.19

Versus estimates

Revenue

Q4 2024$192.0K

Diluted EPS

Q1 2026-$0.33Miss by $0.11
Q4 2025-$0.10Beat by $0.10Q3 2025-$0.21Beat by $0.01Q2 2025-$0.13Beat by $0.10Q1 2025-$0.08Beat by $0.20Q4 2024-$0.64Miss by $0.32

Ask the moment Eledon Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eledon Pharmaceuticals, Inc. report Q1 2026 earnings?
Eledon Pharmaceuticals, Inc. (ELDN) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Eledon Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Eledon Pharmaceuticals, Inc. reported eps of $-0.33 for Q1 2026.
Did Eledon Pharmaceuticals, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.22 by $0.11.
How did Eledon Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 312.5% from $-0.08.
Where can I find Eledon Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-221658) and the 10-Q periodic report (0001193125-26-221702) directly on SEC EDGAR. The filing index links above go to sec.gov.